These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6779820)

  • 61. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 62. [Studies on platelets in a patient with a novel hereditary platelet function disorder--impaired aggregation in response to A 23187 with normal response to arachidonic acid].
    Sugiyama T; Okuma M; Ushikubi F; Kanaji K; Sensaki S; Uchino H; Hattori A; Ihzumi T
    Rinsho Ketsueki; 1986 Oct; 27(10):1834-42. PubMed ID: 3102812
    [No Abstract]   [Full Text] [Related]  

  • 63. Pharmacological interactions between prostacyclin and thromboxanes.
    Whittle BJ; Moncada S
    Br Med Bull; 1983 Jul; 39(3):232-8. PubMed ID: 6313114
    [No Abstract]   [Full Text] [Related]  

  • 64. Insufficient mobilization of calcium by early breakdown of phosphatidylinositol 4,5-bisphosphate for aggregation of human platelets by collagen.
    Narita H; Park HJ; Tanaka K; Matsuura T; Kito M
    J Biochem; 1985 Oct; 98(4):1063-8. PubMed ID: 3001036
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 69. All cis-5, 8, 11, 14, 17 eicosapentaenoic acid and triene prostaglandins: potential anti-thrombotic agents.
    Dyerberg J; Bang HO
    Scand J Clin Lab Invest; 1980; 40(7):589-93. PubMed ID: 6258218
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

  • 71. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 72. Platelet membrane molecular organization: relationship with membrane bound calcium.
    Rendu F; Viret J; Daveloose D; Levy-Toledano S; Leterrier F
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1048-53. PubMed ID: 2983699
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vitamin E inhibits the release of calcium from a platelet fraction in vitro.
    Butler AM; Gerrard JM; Peller J; Stoddard SF; Rao GH; White JG
    Prostaglandins Med; 1979 Mar; 2(3):203-16. PubMed ID: 121605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platelet aggregation and thromboxane A2 formation in cat platelet rich plasma.
    Marcinkiewicz E; Grodzińska L; Gryglewski RJ
    Pharmacol Res Commun; 1978 Jan; 10(1):1-12. PubMed ID: 643889
    [No Abstract]   [Full Text] [Related]  

  • 75. Synthesis of stable thromboxane A2 analogs: pinane thromboxane A2 (PTA2) and carbocyclic thromboxane A2 (CTA2).
    Nicolaou KC; Magolda RL
    Methods Enzymol; 1982; 86():400-9. PubMed ID: 7132765
    [No Abstract]   [Full Text] [Related]  

  • 76. Platelet effects of arachidonic acid in dog blood. II. Involvement of cyclo-oxygenase in the in vitro situation.
    Chignard M; Lefort J; Vargaftig BB
    Prostaglandins; 1977 Nov; 14(5):929-46. PubMed ID: 594393
    [No Abstract]   [Full Text] [Related]  

  • 77. Mariannaepyrone--a new inhibitor of thromboxane A2 induced platelet aggregation.
    Fabian K; Anke T; Sterner O
    Z Naturforsch C J Biosci; 2001; 56(1-2):106-10. PubMed ID: 11302199
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Albumin stabilizes thromboxane A2.
    Folco G; Granström E; Kindahl H
    FEBS Lett; 1977 Oct; 82(2):321-4. PubMed ID: 913605
    [No Abstract]   [Full Text] [Related]  

  • 79. Receptor and non receptor-mediated activation of blood platelets. Effect on membrane-cytoskeleton interaction.
    Rotman A
    Biochem Biophys Res Commun; 1984 May; 120(3):898-906. PubMed ID: 6428402
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fatty acids bound to serumalbumin decrease the half-life of thromboxane A2.
    Lagarde M; Velardo B; Blanc M; Dechavanne M
    Prostaglandins; 1980 Aug; 20(2):275-83. PubMed ID: 7413992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.